Tryg (CPSE:TRYG) Holds To Its 2027 Targets, Is The Stock Fully Priced?

Tryg (CPSE:TRYG) has drawn fresh attention after recent share price moves, with the stock showing mixed short term returns but a stronger pattern over the past month and past 3 months.

Recent trading has been choppy for Tryg, with a modest 1-day share price move and a slightly weaker 7-day share price return. However, momentum has picked up, with a 30-day share price return of 10.61% and a 90-day share price return of 6.99%.

Set against this shorter-term pattern, the picture over longer horizons looks steadier. The 1-year total shareholder return stands at 6.49% and the 3-year total shareholder return at 33.15%, which suggests investors have been rewarded over time, even if the year-to-date share price return of 0.85% is softer.

Scan how Tryg compares with other insurers, which show firm recent momentum and solid financial profiles, by reviewing the curated 206 resilient stocks with low risk scores.

The recent climb in Tryg, set against only modest year to date gains, leaves a simple question hanging: Does the current price still compensate you for the risks on the table, or has the easy reward already been taken?

Most Popular Narrative: 1% Undervalued

Tryg's last close at DKK163.7 sits just below the analyst consensus Narrative fair value of DKK165.67, pointing to only a modest valuation gap when using a 5.5% discount rate and the earnings path embedded in that work.

The company continues to work toward its insurance service result target of DKK 8.0b to DKK 8.4b and a combined ratio around 81% for 2027, and reiterated in 2026 that these goals are unchanged, which ties its operational programmes directly to future revenue and earnings potential.

See why 26 investors see Tryg as 1% undervalued.

Result: Fair Value of DKK165.67 (UNDERVALUED)

Still, the Tryg narrative can be knocked off course if inflation keeps forcing price hikes that test customer loyalty, or if regulatory scrutiny on indexation compresses profitability.

Find out about the key risks to this Tryg narrative.

Another View on Tryg’s Valuation

The first narrative leans on future cash flows and a DKK165.67 fair value, yet the current DKK163.7 share price tells a more mixed story when profit multiples come into play. Tryg trades on a P/E of 21x, compared with 16.3x for peers and 12.8x for the wider European insurance group. The fair ratio sits higher at 23.5x, suggesting the market could shift either toward a richer rating or closer to industry levels. Which side of that range do you think carries more risk for you as a shareholder?

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Sentiment around Tryg is mixed, which is exactly when doing your own homework matters most. Move quickly, weigh the upside and downside, and check the 2 key rewards and 1 important warning sign.

Looking for more investment ideas beyond Tryg?

If Tryg has sharpened your focus on quality, now is the moment to widen your watchlist before the next set of opportunities moves out of reach.

• Target companies the market may be underpricing today by scanning the 195 high quality undervalued stocks.
• Strengthen the defensive side of your portfolio with a diversified 214 dividend fortresses that can help support more dependable income.
• Prioritise resilience by filtering for proven balance sheets using the list of solid balance sheet and fundamentals (198 results).

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com